Cardiome Pharma ([[CRME] +4.2%) trades up on the back of Merck's ([[MRK] +0.5%) announcement...

|About: Cardiome Pharma Corporation (CRME)|By:, SA News Editor

Cardiome Pharma ([[CRME] +4.2%) trades up on the back of Merck's ([[MRK] +0.5%) announcement that it will return the global marketing and development rights for both the intravenous and oral formulations for vernakalant to CRME.